These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19596786)

  • 1. ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo.
    Muraoka-Cook RS; Sandahl MA; Strunk KE; Miraglia LC; Husted C; Hunter DM; Elenius K; Chodosh LA; Earp HS
    Mol Cell Biol; 2009 Sep; 29(18):4935-48. PubMed ID: 19596786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
    Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
    Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation.
    Feng SM; Muraoka-Cook RS; Hunter D; Sandahl MA; Caskey LS; Miyazawa K; Atfi A; Earp HS
    Mol Cell Biol; 2009 Feb; 29(3):892-906. PubMed ID: 19047365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation.
    Muraoka-Cook RS; Sandahl M; Hunter D; Miraglia L; Earp HS
    Mol Endocrinol; 2008 Oct; 22(10):2307-21. PubMed ID: 18653779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation.
    Jones FE; Welte T; Fu XY; Stern DF
    J Cell Biol; 1999 Oct; 147(1):77-88. PubMed ID: 10508857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients.
    Machleidt A; Buchholz S; Diermeier-Daucher S; Zeman F; Ortmann O; Brockhoff G
    BMC Cancer; 2013 Sep; 13():437. PubMed ID: 24063248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor α is not expressed.
    Munk M; Memon A; Poulsen SS; Borre M; Nexo E; Sorensen BS
    Scand J Clin Lab Invest; 2013 Sep; 73(6):503-13. PubMed ID: 24015958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
    Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
    Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration.
    Gambarotta G; Garzotto D; Destro E; Mautino B; Giampietro C; Cutrupi S; Dati C; Cattaneo E; Fasolo A; Perroteau I
    J Biol Chem; 2004 Nov; 279(47):48808-16. PubMed ID: 15355992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation.
    Williams MM; Vaught DB; Joly MM; Hicks DJ; Sanchez V; Owens P; Rahman B; Elion DL; Balko JM; Cook RS
    Breast Cancer Res; 2017 Sep; 19(1):105. PubMed ID: 28886748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.
    Kiuchi T; Ortiz-Zapater E; Monypenny J; Matthews DR; Nguyen LK; Barbeau J; Coban O; Lawler K; Burford B; Rolfe DJ; de Rinaldis E; Dafou D; Simpson MA; Woodman N; Pinder S; Gillett CE; Devauges V; Poland SP; Fruhwirth G; Marra P; Boersma YL; Plückthun A; Gullick WJ; Yarden Y; Santis G; Winn M; Kholodenko BN; Martin-Fernandez ML; Parker P; Tutt A; Ameer-Beg SM; Ng T
    Sci Signal; 2014 Aug; 7(339):ra78. PubMed ID: 25140053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events.
    Clark DE; Williams CC; Duplessis TT; Moring KL; Notwick AR; Long W; Lane WS; Beuvink I; Hynes NE; Jones FE
    J Biol Chem; 2005 Jun; 280(25):24175-80. PubMed ID: 15863494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5.
    Long W; Wagner KU; Lloyd KC; Binart N; Shillingford JM; Hennighausen L; Jones FE
    Development; 2003 Nov; 130(21):5257-68. PubMed ID: 12954715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.
    Nielsen TO; Sorensen S; Dagnæs-Hansen F; Kjems J; Sorensen BS
    Br J Cancer; 2013 Jun; 108(11):2291-8. PubMed ID: 23695025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.
    Muraoka-Cook RS; Feng SM; Strunk KE; Earp HS
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):235-46. PubMed ID: 18437540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
    Teulière J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA
    Development; 2005 Jan; 132(2):267-77. PubMed ID: 15590737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
    Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
    PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.
    Vidal GA; Naresh A; Marrero L; Jones FE
    J Biol Chem; 2005 May; 280(20):19777-83. PubMed ID: 15746097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary gland-specific nuclear factor activity is positively regulated by lactogenic hormones and negatively by milk stasis.
    Schmitt-Ney M; Happ B; Hofer P; Hynes NE; Groner B
    Mol Endocrinol; 1992 Dec; 6(12):1988-97. PubMed ID: 1491685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental stage determines the effects of MYC in the mammary epithelium.
    Blakely CM; Sintasath L; D'Cruz CM; Hahn KT; Dugan KD; Belka GK; Chodosh LA
    Development; 2005 Mar; 132(5):1147-60. PubMed ID: 15689376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.